Expressed on CD8+ T, NK, and CD4+ T cells, CXCR6 could promote the recruitment of tumor-infiltrating lymphocytes in combination with CXCL16 expressed by tumor cells, thus contributing to a better prognosis for cancer patients [17]. This evidence concerns the gene CD4 and neoplasm.